According to Antlerzz, online searches for the GLP-1 semaglutide injection, which was originally intended for type 2 diabetes management, rose 170% in the U.S
The common claims involve faster healing, reduced inflammation, tendon and ligament support, improved recovery after exercise, and help with chronic soft-tissue problems
Other factors that contributed to the coverage change
The Ozempic lawsuit complaints assert claims for, among other things, negligence, strict liability, breach of warranty, negligent/fraudulent misrepresentation, and violation of state statutes
We asked nutritionists Some food companies, including Nestle and Conagra, are responding to the popularity of obesity and diabetes drugs by branding some products "GLP-1 Friendly." The labels target a growing number of consumers taking medicines such as Zepbound and Wegovy who may be looking for healthier, ready-made meals that minimize side-effects from the drugs
Figure 4 Despite its promises, the most relevant barriers in the adoption of digital receipts are individual user burden, retailer resistance, lack of standardization, infrastructure and data privacy
